What has changed in patients with multiple sclerosis after the pandemic? Fatigue, Physical Activity, Sleep Quality, and Anxiety Levels

Abstract

Objective: The aim of this study was to compare the fatigue, physical activity, sleep quality, and anxiety levels in patients with Multiple Sclerosis (PwMS) during the outbreak of COVID-19 compared to pre-COVID-19 outbreak. Material and Methods: In this study, 48 MS patients, whom we routinely followed up, were contacted by e-mail. The participants were asked to complete an online survey that includes sociodemographic data form, the Fatigue Severity Scale (FSS), the International Physical Activity Questionnaire (IPAQ), the Pittsburgh Sleep Quality Index (PSQI), and the anxiety part of the Hospital Anxiety and Depression Scale (HADS). Also, the patients' social isolation time and with whom they lived during this period were recorded. Results: Thirty PwMS, aged 21-58 years, volunteered to participate in the study. We found that physical activity and sleep quality decreased and fatigue increased in the COVID-19 pandemic period (p<0.05). However, no significant difference was found in the level of anxiety (p>0.05). Conclusion: The results of this cross-sectional study suggest that physical activity, sleep quality, and fatigue were more negatively compared to the pre-pandemic values, but no change was observed in anxiety status.

Keywords

• COVID-19
• Multiple Sclerosis
• exercise
• anxiety
• fatigue
• sleep hygiene

Pandemi Sonrası Multipl Skleroz Hastalarında Neler Değişti? Yorgunluk, Fiziksel Aktivite, Uyku Kalitesi ve Anksiyete Düzeyleri

Abstract

ÖZ Amaç: Bu çalışmanın amacı, COVID-19 salgını sırasında Multipl Sklerozlu (MS) hastalarda yorgunluk, fiziksel aktivite, uyku kalitesi ve anksiyete düzeylerini COVID-19 öncesine göre karşılaştırmaktı. Gereç ve Yöntemler: Bu çalışmada rutin olarak takip ettiğimiz 48 MS hastasına e-posta ile ulaşıldı. Katılımcılardan sosyodemografik veri formu, Yorgunluk Şiddet Ölçeği (YŞÖ), Uluslararası Fiziksel Aktivite Anketi (UFAA), Pittsburgh Uyku Kalitesi İndeksi (PUKİ) ve Hastane Anksiyete ve Depresyon Ölçeği'nin (HADÖ) anksiyete bölümünü içeren çevrimiçi bir anketi doldurmaları istendi. Ayrıca hastaların sosyal izolasyon süreleri ve bu dönemde kimlerle yaşadıkları kaydedildi. Bulgular: Yaşları 21-58 arasında olan 30 MS hastası çalışmaya katılmak için gönüllü oldu. COVID-19 pandemi döneminde fiziksel aktivite ve uyku kalitesinin azaldığını ve yorgunluğun arttığını bulduk (p <0,05). Ancak anksiyete düzeyinde anlamlı fark bulunmadı (p> 0,05). Sonuç: Kesitsel tipteki bu çalışmanın sonuçları, fiziksel aktivite, uyku kalitesi ve yorgunluğun pandemi öncesi değerlere göre daha olumsuz olduğunu, ancak anksiyete durumunda herhangi bir değişiklik olmadığını göstermektedir.

Keywords

• COVID-19;
• Multipl Skleroz
• egzersiz
• anksiyete
• yorgunluk
• uyku hijyeni

References

1. Boeschoten, R. E., Braamse, A. M., Beekman, A. T., Cuijpers, P., van Oppen, P., Dekker, J., & Uitdehaag, B. M. (2017). Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. Journal of the neurological sciences, 372, 331-341.
2. Booth, F. W., Roberts, C. K., & Laye, M. J. (2011). Lack of exercise is a major cause of chronic diseases. Comprehensive physiology, 2(2), 1143-1211.
3. Braley, T. J., & Chervin, R. D. (2010). Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. Sleep, 33(8), 1061-1067.
4. Brass, S. D., Duquette, P., Proulx-Therrien, J., & Auerbach, S. (2010). Sleep disorders in patients with multiple sclerosis. Sleep medicine reviews, 14(2), 121-129.
5. Buysse, D. J., Reynolds III, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry research, 28(2), 193-213.
6. Chiaravalloti, N. D., Amato, M. P., Brichetto, G., Chataway, J., Dalgas, U., DeLuca, J., ... & Feinstein, A. (2020). The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis. Journal of neurology, 1-10.
7. Côté, I., Trojan, D. A., Kaminska, M., Cardoso, M., Benedetti, A., Weiss, D., ... & Kimoff, R. J. (2013). Impact of sleep disorder treatment on fatigue in multiple sclerosis. Multiple sclerosis journal, 19(4), 480-489.
8. Craig, C. L., Marshall, A. L., Sjöström, M., Bauman, A. E., Booth, M. L., Ainsworth, B. E., ... & Oja, P. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine & science in sports & exercise, 35(8), 1381-1395.

9. Feinstein, A., Magalhaes, S., Richard, J. F., Audet, B., & Moore, C. (2014). The link between multiple sclerosis and depression. Nature reviews neurology, 10(9), 507.
10. Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994). Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical infectious diseases, 18 (supplement-1), 79-83.
11. Heine, M., van de Port, I., Rietberg, M. B., van Wegen, E. E., & Kwakkel, G. (2015). Exercise therapy for fatigue in multiple sclerosis. Cochrane database of systematic reviews, (9).
12. Honarmand, K., & Feinstein, A. (2009). Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Multiple sclerosis journal, 15(12), 1518-1524.
13. Hunter, S. F. (2016). Overview and diagnosis of multiple sclerosis. The american journal of managed care, 22(6 suppl), 141-150.
14. Kotterba, S., Neusser, T., Norenberg, C., Bussfeld, P., Glaser, T., Dörner, M., & Schürks, M. (2018). Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study. BMC neurology, 18(1), 1-10.
15. Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of neurology, 46(10), 1121-1123.
16. Motl, R. W., Sandroff, B. M., Kwakkel, G., Dalgas, U., Feinstein, A., Heesen, C., ... & Thompson, A. J. (2017). Exercise in patients with multiple sclerosis. The lancet neurology, 16(10), 848-856.
17. Ng, A. V., & Kent-Braun, J. A. (1997). Quantitation of lower physical activity in persons with multiple sclerosis. Medicine and science in sports and exercise, 29(4), 517-523.
18. Ozamiz-Etxebarria, N., Dosil-Santamaria, M., Picaza-Gorrochategui, M., & Idoiaga-Mondragon, N. (2020). Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cadernos de saude publica, 36, e00054020.
19. Özdin, S., & Bayrak Özdin, Ş. (2020). Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. International Journal of social psychiatry, 66(5), 504-511.
20. Pinto, A. J., Dunstan, D. W., Owen, N., Bonfá, E., & Gualano, B. (2020). Combating physical inactivity during the COVID-19 pandemic. Nature reviews rheumatology, 16(7), 347-348.
21. Riether, A. M. (1999). Anxiety in patients with multiple sclerosis. In Seminars in clinical neuropsychiatry (Vol. 4, No. 2, pp. 103-113).
22. Rooney, S., Albalawi, H., & Paul, L. (2020). Exercise in the management of multiple sclerosis relapses: current evidence and future perspectives. Neurodegenerative disease management, 10(2), 99-111.
23. Sadeghi Bahmani, D., Kesselring, J., Papadimitriou, M., Bansi, J., Pühse, U., Gerber, M., ... & Brand, S. (2019). In patients with multiple sclerosis, both objective and subjective sleep, depression, fatigue, and paresthesia improved after 3 weeks of regular exercise. Frontiers in psychiatry, 10, 265.
24. Safari, R., Van der Linden, M. L., & Mercer, T. H. (2017). Effect of exercise interventions on perceived fatigue in people with multiple sclerosis: synthesis of meta-analytic reviews. Neurodegenerative disease management, 7(3), 219-230.
25. Stojanov, A., Malobabic, M., Milosevic, V., Stojanov, J., Vojinovic, S., Stanojevic, G., & Stevic, M. (2020). Psychological status of patients with relapsing-remitting multiple sclerosis during coronavirus disease-2019 outbreak. Multiple Sclerosis and Related Disorders, 45, 102407.
26. World Health Organization. (2020). World Health Organization coronavirus disease (COVID-19) dashboard.
27. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., ... & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine.